company background image
CC logo

Chemours NYSE:CC Stock Report

Last Price

US$17.64

Market Cap

US$2.6b

7D

5.7%

1Y

-41.6%

Updated

12 Jan, 2025

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

The Chemours Company Competitors

Price History & Performance

Summary of share price highs, lows and changes for Chemours
Historical stock prices
Current Share PriceUS$17.64
52 Week HighUS$32.48
52 Week LowUS$15.10
Beta1.81
1 Month Change-7.35%
3 Month Change-11.62%
1 Year Change-41.57%
3 Year Change-51.22%
5 Year Change1.03%
Change since IPO-11.93%

Recent News & Updates

Are Investors Undervaluing The Chemours Company (NYSE:CC) By 50%?

Jan 08
Are Investors Undervaluing The Chemours Company (NYSE:CC) By 50%?

Not Many Are Piling Into The Chemours Company (NYSE:CC) Just Yet

Dec 05
Not Many Are Piling Into The Chemours Company (NYSE:CC) Just Yet

Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright

Nov 21

Recent updates

Are Investors Undervaluing The Chemours Company (NYSE:CC) By 50%?

Jan 08
Are Investors Undervaluing The Chemours Company (NYSE:CC) By 50%?

Not Many Are Piling Into The Chemours Company (NYSE:CC) Just Yet

Dec 05
Not Many Are Piling Into The Chemours Company (NYSE:CC) Just Yet

Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright

Nov 21

Chemours' (NYSE:CC) Earnings Offer More Than Meets The Eye

Nov 12
Chemours' (NYSE:CC) Earnings Offer More Than Meets The Eye

Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)?

Sep 25
Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)?

Chemours: We're Back Down To Trough And A 'BUY'

Sep 01

Chemours: Upside After Irregularities, Good 2024-2026E

Jun 11

The Chemours Company's (NYSE:CC) Low P/S No Reason For Excitement

May 30
The Chemours Company's (NYSE:CC) Low P/S No Reason For Excitement

Drama At The Chemours Company Opens The Door For Upside

Mar 29

The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%

Mar 01
The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%

Chemours: The Case Amidst Board Trouble, I Say Buy The Weakness

Feb 29

Chemours (NYSE:CC) Has Announced A Dividend Of $0.25

Feb 17
Chemours (NYSE:CC) Has Announced A Dividend Of $0.25

Chemours: Technological Innovation Presents Excellent Opportunities For Growth

Dec 23

Chemours (NYSE:CC) Will Pay A Dividend Of $0.25

Oct 30
Chemours (NYSE:CC) Will Pay A Dividend Of $0.25

The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate

Oct 28
The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate

Chemours: Volatile Bottom Line Needs Consistency

Oct 06

The Chemours Company: Portfolio Optimization Resulting In Compounding Growth

Sep 19

Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Jul 18
Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Is There An Opportunity With The Chemours Company's (NYSE:CC) 48% Undervaluation?

Jul 03
Is There An Opportunity With The Chemours Company's (NYSE:CC) 48% Undervaluation?

The Chemours Company: On A Nice Run

Jul 03

Shareholder Returns

CCUS ChemicalsUS Market
7D5.7%-0.5%-2.1%
1Y-41.6%-2.8%21.3%

Return vs Industry: CC underperformed the US Chemicals industry which returned -2.8% over the past year.

Return vs Market: CC underperformed the US Market which returned 21.3% over the past year.

Price Volatility

Is CC's price volatile compared to industry and market?
CC volatility
CC Average Weekly Movement7.7%
Chemicals Industry Average Movement5.3%
Market Average Movement6.4%
10% most volatile stocks in US Market18.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: CC has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CC's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20146,200Denise M. Dignamwww.chemours.com

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

The Chemours Company Fundamentals Summary

How do Chemours's earnings and revenue compare to its market cap?
CC fundamental statistics
Market capUS$2.64b
Earnings (TTM)US$76.00m
Revenue (TTM)US$5.75b

34.7x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CC income statement (TTM)
RevenueUS$5.75b
Cost of RevenueUS$4.62b
Gross ProfitUS$1.13b
Other ExpensesUS$1.06b
EarningsUS$76.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.51
Gross Margin19.71%
Net Profit Margin1.32%
Debt/Equity Ratio605.8%

How did CC perform over the long term?

See historical performance and comparison

Dividends

5.7%

Current Dividend Yield

196%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 04:02
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

The Chemours Company is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAlembic Global Advisors
David ColemanArgus Research Company
Ishan MajumdarBaptista Research